PBKM subsidiary buys Biocell Lugano
22:31
Famicord, a subsidiary of Polish stem cell bank PBKM, acquired 100 percent of shares in Biocell Lugano, PBKM said in a statement. The maximum price is set at €1.6 million (PLN 6.9 million).
Under the agreement, the payment will be executed in three tranches of PLN 0.25 million, PLN 0.75 million and PLN 0.5 million. There is also a possible conditional payment of PLN 0.1 million, which depends on the increase of Biocell Lugano sales in 2018 or 2019.
The transfer of share ownership to Famicord will be effective after payment of the first tranche.
